Pressure to be nimble and responsive is mirrored at each of the trial sites. Given the urgent needs of patients—and thanks to LLS’s hands-on partnering with the FDA—positive data can move the drug straight to registration. This means all the data must be clean from the get-go, and some traditional steps must be compressed. For example, Syneos Health and its partners are testing a novel clinical data “pipe” that can funnel information directly from patients’ electronic records into the main database, skipping a traditional transcription step that’s both time-consuming and vulnerable to errors.

Join for free to read